Press-release for stocks publishing date 2021 - 03

Prices are updated after-hours

therapeutics publishing date : 2021 - 03 - 01

save search

Avita Medical, Inc. Announces Closing of Offering of 3,214,250 Shares of Common Stock
Published: 2021-03-01 (Crawled : 00:00) - globenewswire.com
RCEL | $8.64 -2.59% -2.66% 390K

Health Technology

| -59.8% | O: 6.79% H: 1.57% C: 0.0%
offering

Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2020 Financial Results and Recent Corporate Developments
Published: 2021-03-01 (Crawled : 22:03) - globenewswire.com
SRPT | $115.53 -0.88% -0.9% 640K

Health Technology

| 32.85% | O: -1.94% H: 5.46% C: 4.21%
financial results results

Corcept Therapeutics Expands Executive Team; Atabak Mokari Joins As Chief Financial Officer; Charles Robb Named Chief Business Officer
Published: 2021-03-01 (Crawled : 22:00) - globenewswire.com
CORT | $22.97 1.37% 1.35% 920K

Health Technology

| -9.86% | O: 0.16% H: 0.43% C: -2.82%

Acer Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
Published: 2021-03-01 (Crawled : 22:00) - globenewswire.com
ACER | $0.9 -3.61% 420K

Health Technology

| -72.31% | O: 7.76% H: 0.0% C: -8.91%
financial results results

Agile Therapeutics Reports Fourth Quarter & Full Year 2020 Financial Results; Expands Loan Facility With Perceptive Advisors
Published: 2021-03-01 (Crawled : 22:00) - globenewswire.com
AGRX | $0.37 0.0% 15K

Health Technology

| -87.42% | O: -4.64% H: 0.0% C: -10.42%
financial results results

Morphic Therapeutic Announces Proposed Public Offering
Published: 2021-03-01 (Crawled : 21:03) - globenewswire.com
MORF | $28.0 1.78% 1.75% 380K

Health Technology

| -67.01% | O: -12.2% H: 7.07% C: -4.62%
offering therapeutics publication

VYNE Therapeutics to Present at the Cowen 41st Annual Health Care Conference
Published: 2021-03-01 (Crawled : 21:03) - globenewswire.com
VYNE | $2.285 -0.65% -0.66% 19K

Health Technology

| -69.76% | O: 1.61% H: 3.17% C: -3.7%
health

Travere Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
Published: 2021-03-01 (Crawled : 21:03) - globenewswire.com
TVTX | $5.73 -1.21% -1.22% 950K

Health Technology

| -81.28% | O: -4.78% H: 4.78% C: 0.31%
financial results results

Turning Point Therapeutics Reports Fourth-Quarter and Full-Year Financial Results, Provides Operational Updates
Published: 2021-03-01 (Crawled : 21:03) - globenewswire.com
TPTX | $76.01 -0.03%

Health Technology

| -37.31% | O: -1.75% H: 3.76% C: -1.82%
financial results results

Hoth Therapeutics Completes Site Recruitment for Cohort 1 of First in Human Clinical Trial of BioLexa for the Treatment of Atopic Dermatitis
Published: 2021-03-01 (Crawled : 21:00) - biospace.com/
HOTH | $1.22 3.39% 3.28% 22K

Health Technology

| -48.94% | O: 0.0% H: 5.02% C: -1.7%
treatment dermatitis trial atopic dermatitis

Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Business Update on March 11, 2021
Published: 2021-03-01 (Crawled : 19:00) - biospace.com/
LCTX | $1.15 -4.17% 0.0% 1.1M

Health Technology

| -50.0% | O: 0.0% H: 10.87% C: 4.78%
financial results results

OncoSec Announces Publication in Clinical Cancer Research of Data Supporting the Therapeutic Potential of Lead Product Candidate, TAVO™, in Triple Negative Breast Cancer
Published: 2021-03-01 (Crawled : 19:00) - biospace.com/
ONCS | $0.2772 25.59% 52M

Health Services

| -94.96% | O: 4.0% H: 1.05% C: -0.17%
cancer research breast cancer potential

Checkpoint Therapeutics Announces Formation of Scientific Advisory BoardMembers include preeminent clinical and scientific thought leaders in oncology
Published: 2021-03-01 (Crawled : 19:00) - biospace.com/
CKPT | $1.47 -8.13% -8.84% 760K

Health Technology

| -54.52% | O: 4.05% H: 4.79% C: -0.6%

Kazia Licenses Cantrixil, a Clinical-stage, First-in-class Ovarian Cancer Drug Candidate, to Oasmia Pharmacetical AB
Published: 2021-03-01 (Crawled : 19:00) - biospace.com/
KZIA | $0.379 9.47% 8.65% 300K

Health Technology

| -96.2% | O: 2.2% H: 12.05% C: 2.74%
cancer drug license ovarian cancer

Sorrento Therapeutics and Scilex Holding, a Majority Owned Subsidiary, Have Entered Into an Exclusive Licensing Term Sheet With Aardvark Therapeutics to Acquire Its ARD-301 For the Treatment of Chronic Pain, Fibromyalgia, and Chronic Long Haul Covid Syndrome
Published: 2021-03-01 (Crawled : 18:00) - globenewswire.com
SRNE | $0.024 -8.85% 57K

Health Technology

| -99.79% | O: 4.1% H: 6.2% C: 1.83%
covid treatment fibromyalgia license chronic pain syndros

Cyclo Therapeutics Appoints Gerald F. Cox, MD, PhD as Acting Chief Medical Officer
Published: 2021-03-01 (Crawled : 14:14) - ir.stockpr.com
CYTH | $1.19 -0.83% -0.84% 57K

Professional, Scientific, and T...

| -86.11% | O: 1.8% H: 4.59% C: 1.41%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| 0.89% | O: 0.37% H: 0.5% C: -0.33%

Chinook Therapeutics and Evotec Announce Strategic Collaboration to Discover and Develop Novel Precision Medicines for Chronic Kidney Diseases
Published: 2021-03-01 (Crawled : 14:01) - globenewswire.com
KDNY | $40.39 0.22% -0.17% 0

Health Technology

| 144.2% | O: 1.27% H: 5.29% C: 2.87%
disease kidney diseases collaboration kidney

Qualigen Therapeutics Secures Option to Negotiate License for G-Quadruplex Anti-Cancer Technology from UCL
Published: 2021-03-01 (Crawled : 14:01) - globenewswire.com
QLGN | $0.301 -3.43% -3.55% 30K

Health Technology

| -90.27% | O: 6.38% H: 0.57% C: -2.0%
cancer license

Checkpoint Therapeutics Announces Formation of Scientific Advisory Board
Published: 2021-03-01 (Crawled : 14:00) - globenewswire.com
CKPT | $1.47 -8.13% -8.84% 760K

Health Technology

| -54.52% | O: 4.05% H: 4.79% C: -0.6%
therapeutics

Acer Therapeutics to Participate in March Virtual Investor Conferences
Published: 2021-03-01 (Crawled : 14:00) - globenewswire.com
ACER | $0.9 -3.61% 420K

Health Technology